BSH Certifies Evoqua SeaCURETM Ballast Water Treatment System for Wide Range of Flow Rates

  • Bundesamt für Seeschifffahrt und Hydrographie (BSH) certifies SeaCURE Ballast Water System for 500-4,000m3/hour
  • SeaCURE BWT system IMO type approved and also USCG AMS accepted to operate in all salinities
  • SeaCURE BWT system based on proven, widely deployed Chloropac® marine growth prevention system (MGPS) technology
  • Solution available in skid-mounted version for new builds or as modular components for retrofits

ALPHARETTA, Ga.--()--The Federal Maritime and Hydrographic Agency of Germany (Bundesamt für Seeschifffahrt und Hydrographie- BSH), which previously granted the Evoqua SeaCURETM Ballast Water Management (BWT) system type approval, has now certified the SeaCURE system to operate in volumes from 500-4,000m3/hr. suitable for a wide range of container, LNG, tanker and other vessels.

In addition to IMO type approval, the SeaCURE system also is USCG AMS accepted to operate in all salinities.

The SeaCURE system utilizes a patented process* that first injects biocide into ballast seawater before it reaches the large surface filter intakes to reduce the growth of marine organisms that can clog the filters. Next, Chloropac® concentric tubular electrodes (CTE) generate sodium hypochlorite from the natural salinity in sea water which eliminates the need to purchase biocides and store or replenish them onboard.

The SeaCURE system also features low energy requirements and low maintenance costs due to the self-cleaning feature of the CTE technology. Proprietary control logic monitors the biocide dose level necessary to provide the required efficacy depending on ballast water conditions. Chloropac electrodes have been proven in more than 2,500 installations worldwide over the past 35 years.

“The SeaCURE system can benefit ship owners of any size and particularly those who value low operating costs and who need the flexibility of a BWT system that can be deployed on any trade lane regardless of salinity,” said SeaCURE Product Manager David Palmer.

The SeaCURE system is available as a compact skid or as modular components depending on customer requirements for installation in new builds and existing ships.

It is particularly well-suited for retrofit installations because biocide generation takes place in a small side stream from the ballast water main to minimize footprint and maximize available space. The side stream generation method offers advantages for installation on tankers because the modules can be placed in a way that only the filter and analyzer module are installed in the hazardous area of the cargo pump room, while the main parts of the system remain in the safe area.

To learn more about the SeaCURE system, click here.

* Certain features of the process, system or products are covered by pending or granted patents in some countries. Further information will be provided upon request.

Chloropac and SeaCURE are trademarks of Evoqua Water Technologies in some countries.

About Evoqua Water Technologies LLC

Evoqua Water Technologies is a leader in water and wastewater treatment products, systems and services for industrial, marine and municipal customers. Its comprehensive, cost-effective and reliable treatment systems and services reduce fresh water demand, ensure uninterrupted quantity and quality of water, and enable regulatory and environmental compliance. With a wide range of proven product brands and advanced water and wastewater treatment technologies, mobile and emergency water supply solutions and service contract options, Evoqua helps cities provide clean water and industrial plants to maintain productivity and profitability. For more information, visit www.evoqua.com.

Contacts

Evoqua Water Technologies LLC
John Deaver, +1 (404) 937-1562
Director of Communications
john.deaver@evoqua.com

Release Summary

BSH has certified the Evoqua SeaCURE BWT system to operate in volumes from 500-4,000m3/hr. suitable for a wide range of vessels.

Contacts

Evoqua Water Technologies LLC
John Deaver, +1 (404) 937-1562
Director of Communications
john.deaver@evoqua.com